Delivery Order SPE2DB24D1006-SPE2DB25FCFAW
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Eliquis 5 mg tablets in a quantity of 60 units, with a ceiling value of $40,426.04. This is a firm fixed price delivery order with no set-aside designation, competitively awarded through open competition. The order is scheduled for completion by September 25, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) valued at $3,271.68 with a firm fixed price structure and an ultimate completion date of August 12, 2025. This is a non-set-aside, competitively awarded delivery order executed under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), which is valued at $999.999 billion and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg on August 15, 2025, with a ceiling value of $14,386.37. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award based on merit. The order is scheduled for completion by August 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Eliquis 5 mg tablets (60-count units) with a ceiling value of $39,270.67. This non-competitive, firm fixed-price delivery order is scheduled for completion by June 3, 2025, and will be performed at the vendor's facility in Conshohocken, Pennsylvania. The award represents a continuation of pharmaceutical supply fulfillment under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Eliquis 5 mg tablets (60-count units) with a ceiling value of $14,787.00. This firm fixed-price delivery order, which is set to be completed by August 12, 2025, will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The award represents a competitive procurement with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count) on August 26, 2025, with a ceiling value of $8,372.86 and completion date of August 27, 2025. This is a firm fixed-price delivery order under a non-set-aside competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Eliquis 5 mg tablets (60-count) valued at $14,097.60. This firm fixed-price delivery order is scheduled for completion by August 12, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The award was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Eliquis 5 mg tablets in quantities of 60 units, with a contract ceiling value of $30,729.43. This is a firm fixed-price delivery order with an ultimate completion date of September 10, 2025, and no set-aside designation was utilized. The award represents a competitive procurement through an open competition process, consistent with AmerisourceBergen's pattern of federal...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) with a ceiling value of $27,309.78. This firm fixed-price delivery order is scheduled for completion by July 11, 2025, and will be fulfilled from the contractor's location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Eliquis 5 mg tablets (60-count packaging) valued at $9,390.02. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively pursued. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters, and the order is scheduled for completion by September 12,...
- SPE2DB24D1006Indefinite Delivery Contract
- SPE2DB24D1006-SPE2DB25FCFAWDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg on August 21, 2025, with a ceiling value of $8,940.84 under a firm fixed price contract. This competitively awarded, non-set-aside delivery order is scheduled for completion by August 22, 2025, with performance based in Conshohocken, Pennsylvania. The award represents a single delivery order issued under AmerisourceBergen's broader federal contract portfolio supporting military and veteran healthcare systems. This delivery order falls under AmerisourceBergen's significant Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of brand-name and generic medications, vaccines, and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen maintains an extensive portfolio of delivery orders across multiple therapeutic domains, demonstrating its capability to meet federal medical procurement requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.9k | 8/21/25 |